- Home
- / Pharmstandard
Pharmstandard
Revenue
₽142.9 B
FY, 2023
Pharmstandard Summary
Company Summary
- Overview
- Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products. It offers medicines for the treatment of cardiovascular diseases, diabetes mellitus, growth hormone deficiency, gastroenterological and infectious diseases, neurological disorders, metabolic disorders, oncology, etc.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2003
- HQ
- Dolgoprudny, RU | view all locations
- Website
- https://pharmstd.com/
- Cybersecurity rating
Table of Contents
Key People
Viktor Kharitonin, Executive Director
LocationsView all
5 locations detected
Dolgoprudny, МО HQ
Russian Federation
5B Likhachevsky proezd
Kursk, Kursk Oblast
Russian Federation
1a/18, 2-ya Agregatnaya street
Moscow
Russian Federation
North Tower, Business Centre, 1 entrance, 10 Testovskaya street
Tomsk, Tomskaya oblast'
Russian Federation
211, Prospekt Lenina
Ufa, Republic of Bashkortostan
Russian Federation
28, Khudayberdina str.
Pharmstandard Financials
Summary Financials
- Revenue (FY, 2023)
- ₽142.9B
- Gross profit (FY, 2023)
- ₽33.6B
- Net income (FY, 2023)
- ₽23.3B
- Cash (FY, 2023)
- ₽5.1B
- EBIT (FY, 2023)
- ₽23.9B